These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8142297)

  • 61. 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5.
    Huang Z; Guengerich FP; Kaminsky LS
    Carcinogenesis; 1998 May; 19(5):867-72. PubMed ID: 9635876
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
    Grimm SW; Dyroff MC
    Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of estrogen biosynthesis and its consequences on gonadotrophin secretion in the male.
    Bhatnagar AS; Müller P; Schenkel L; Trunet PF; Beh I; Schieweck K
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):437-43. PubMed ID: 1532903
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characteristics of estrogen-2/4-hydroxylase in pig blastocysts: inhibition by steroidal and nonsteroidal agents.
    Chakraborty C; Davis DL; Dey SK
    J Steroid Biochem; 1988 Aug; 31(2):231-5. PubMed ID: 2841540
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.
    Pérez N; Borja J
    J Int Med Res; 1992 Aug; 20(4):303-12. PubMed ID: 1387368
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
    Brodie AM; Santen RJ
    Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Aromatase inhibitors: pharmacological aspects].
    de Crémoux P
    Bull Cancer; 2000 Dec; 87 Spec No():23-29. PubMed ID: 11250605
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical use of aromatase inhibitors in human breast carcinoma.
    Santen RJ
    J Steroid Biochem Mol Biol; 1991; 40(1-3):247-53. PubMed ID: 1835644
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450.
    Zhou D; Cam LL; Laughton CA; Korzekwa KR; Chen S
    J Biol Chem; 1994 Jul; 269(30):19501-8. PubMed ID: 8034720
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Substrate dependency of specific and non-specific estrogen-2/4-hydroxylase activities measured by the radio-enzymatic method in rat brain microsomes.
    Theron CN; Russell VA; Taljaard JJ
    J Steroid Biochem; 1986 Oct; 25(4):585-91. PubMed ID: 3773530
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.
    Lønning PE; Jacobs S; Jones A; Haynes B; Powles T; Dowsett M
    Br J Cancer; 1991 May; 63(5):789-93. PubMed ID: 1828173
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Microsomal 25-hydroxylation of vitamin D2 and vitamin D3 in pig liver.
    Axén E; Bergman T; Wikvall K
    J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):97-106. PubMed ID: 7947356
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
    Tekmal RR; Durgam VR
    Cancer Lett; 1997 Sep; 118(1):21-8. PubMed ID: 9310256
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fourteen-day oral combination dose toxicity study of CGS 16949 A (aromatase inhibitor) with 5-fluorouracil or tamoxifen in rats.
    Matsuda A; Higuchi K; Karasawa M; Yoneyama S; Deguchi J; Miyamoto M
    J Toxicol Sci; 1997 Feb; 22(1):1-24. PubMed ID: 9076654
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estrogen metabolism in microsomal, cell, and tissue preparations of kidney and liver from Syrian hamsters.
    Beleh MA; Lin YC; Brueggemeier RW
    J Steroid Biochem Mol Biol; 1995 May; 52(5):479-89. PubMed ID: 7748813
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
    Tominaga T; Yoshida Y; Shimozuma K; Hayashi K; Kosaki G
    Eur J Cancer; 1990; 26(5):600-3. PubMed ID: 2144748
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition and inactivation of equine aromatase by steroidal and non-steroidal compounds. A comparison with human aromatase inhibition.
    Moslemi S; Seralini GE
    J Enzyme Inhib; 1997 Dec; 12(4):241-54. PubMed ID: 9502046
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro and in vivo studies with aromatase inhibitor 4-hydroxy-androstenedione.
    Brodie AM; Wing LY
    Steroids; 1987; 50(1-3):89-103. PubMed ID: 3504069
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Androgens inhibit the formation of catechol estrogens by estrogen 2-hydroxylase present in rat liver microsomal preparations.
    Brueggemeier RW; Bannan RA
    J Steroid Biochem; 1986 Sep; 25(3):351-4. PubMed ID: 3022073
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structure-activity relationships of the inhibition of human placental aromatase by imidazole drugs including ketoconazole.
    Ayub M; Levell MJ
    J Steroid Biochem; 1988 Jul; 31(1):65-72. PubMed ID: 3398530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.